Fundraising Fox

Axial Biotherapeutics

Boston, US · Founded 2013 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

Axial Biotherapeutics was founded in 2013 by SARKIS K. MAZMANIAN.

SK
SARKIS K. MAZMANIANFounder
DH
DAVID H. DONABEDIANCHIEF EXECUTIVE OFFICER OF THE ISSUERPartner, NewCo Formation at Longwood Fund
RC
Ronald C. Renaud Jr.Named on SEC filing
HW
Henry WolfNamed on SEC filing

Board

JC
JAMES C. BLAIRBoard director
MD
MICHELLE DIPPBoard director

Investors · 2

Domain PartnersreportedPrinceton
Longwood FundreportedBoston

Reported raises · per SEC filings

Form D private placements

$109.8M disclosed across 7 rounds · 2016–2025

▶$19.4MraisedFeb 2025 · 29 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • SARAH MEIBUSCHDirector
  • SCOTT C. BRUNDirector
  • REBECCA SENTERExecutive Officer
  • NORA FREYDirector
  • A. STEWART CAMPBELLExecutive Officer, Director
  • Michele CuculluDirector
  • SARKIS K. MAZMANIANDirector
Offering amount
$22M
Amount sold
$19.4M
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.1MraisedOct 2023 · 35 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • JEFFREY E. YOUNGExecutive Officer
  • SARAH MEIBUSCHDirector
  • SCOTT C. BRUNDirector
  • RICHARD P. ALDRICHDirector
  • MARK OHORIDirector
  • JAMES C. BLAIRDirector
  • SAKAE ASANUMADirector
  • A. STEWART CAMPBELLExecutive Officer, Director
  • NORA FREYDirector
  • SARKIS K. MAZMANIANDirector
Offering amount
$24M
Amount sold
$11.1M
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$27.4MraisedOct 2021 · 38 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • SAKAE ASANUMADirector
  • RICHARD P. ALDRICHDirector
  • NORA FREYDirector
  • SCOTT BRUNDirector
  • SARKIS K. MAZMANIANDirector
  • JEFFREY E. YOUNGExecutive Officer
  • A. STEWART CAMPBELLExecutive Officer, Director
  • MARK OHORIDirector
  • JAMES C. BLAIRDirector
  • SARAH MEIBUSCHDirector
  • RONALD C. RENAUD JR.Director
Offering amount
$37.8M
Amount sold
$27.4M
Finders' fees
$500K
Placement agents
JMP SECURITIES LLC
First sale
May 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.8MraisedMay 2020 · 21 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • JEFFREY YOUNGExecutive Officer
  • SAKAE ASANUMADirector
  • RICHARD P. ALDRICHDirector
  • SCOTT BRUNDirector
  • SARKIS K. MAZMANIANDirector
  • Ronald C. Renaud Jr.Director
  • JAMES C. BLAIRDirector
  • Eric De La FortelleDirector
  • DAVID H. DONABEDIANExecutive Officer, Director
  • Henry WolfDirector
Offering amount
$8M
Amount sold
$7.8M
First sale
May 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJun 2019 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES C. BLAIRDirector
  • DAVID H. DONABEDIANExecutive Officer, Director
  • SARKIS K. MAZMANIANDirector
  • RICHARD P. ALDRICHDirector
  • Henry WolfDirector
  • Eric De La FortelleDirector
  • SAKAE ASANUMADirector
  • JEFFREY YOUNGExecutive Officer
  • Ronald C. Renaud Jr.Director
Offering amount
$10M
Amount sold
$5M
First sale
Jun 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedNov 2018 · 36 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • JEFFREY YOUNGExecutive Officer
  • SARKIS K. MAZMANIANDirector
  • Henry WolfDirector
  • JAMES C. BLAIRDirector
  • RICHARD P. ALDRICHDirector
  • Ronald C. Renaud Jr.Director
  • DAVID H. DONABEDIANExecutive Officer, Director
Offering amount
$28M
Amount sold
$20M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.1MraisedJun 2017 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • SARKIS K. MAZMANIANDirector
  • JAMES C. BLAIRDirector
  • Ronald C. Renaud Jr.Director
  • DAVID H. DONABEDIANExecutive Officer
  • MICHELLE DIPPDirector
  • Henry WolfDirector
Offering amount
$19.1M
Amount sold
$19.1M
Minimum investment
$150K
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Axial Biotherapeutics?
Axial Biotherapeutics was founded by SARKIS K. MAZMANIAN in 2013.
Who are Axial Biotherapeutics's investors?
Axial Biotherapeutics's investors include Domain Partners, Longwood Fund.
How much funding has Axial Biotherapeutics raised?
Axial Biotherapeutics has disclosed $109.8M raised across 7 rounds.
Where is Axial Biotherapeutics headquartered?
Axial Biotherapeutics is headquartered in Boston, US.